Connection
William Steinbach to Clinical Trials as Topic
This is a "connection" page, showing publications William Steinbach has written about Clinical Trials as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.337 |
|
|
|
-
Steinbach WJ, Lamoth F, Juvvadi PR. Potential Microbiological Effects of Higher Dosing of Echinocandins. Clin Infect Dis. 2015 Dec 01; 61 Suppl 6:S669-77.
Score: 0.109
-
Steinbach WJ, Benjamin DK. New antifungal agents under development in children and neonates. Curr Opin Infect Dis. 2005 Dec; 18(6):484-9.
Score: 0.054
-
Steinbach WJ. Antifungal agents in children. Pediatr Clin North Am. 2005 Jun; 52(3):895-915, viii.
Score: 0.052
-
Steinbach WJ. New findings and unique aspects in pediatric aspergillosis. Med Mycol. 2005 May; 43 Suppl 1:S261-5.
Score: 0.052
-
Zaas AK, Steinbach WJ. Micafungin: the US perspective. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):183-90.
Score: 0.052
-
Zaoutis T, Lehrnbecher T, Groll AH, Steinbach WJ, Jafri HS, Maertens J, Ngai AL, Chow JW, Taylor AF, Strohmaier KM, Bourque M, Bradshaw SK, Petrecz M, Kartsonis NA. Safety experience with caspofungin in pediatric patients. Pediatr Infect Dis J. 2009 Dec; 28(12):1132-5.
Score: 0.018